These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22202150)

  • 41. The Future of Radioligand Therapy: α, β, or Both?
    Haberkorn U; Giesel F; Morgenstern A; Kratochwil C
    J Nucl Med; 2017 Jul; 58(7):1017-1018. PubMed ID: 28408527
    [No Abstract]   [Full Text] [Related]  

  • 42. Envisaging an alpha therapy programme in the atomic energy establishments: the priorities and the nuances.
    Basu S; Banerjee S
    Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1244-1246. PubMed ID: 28364163
    [No Abstract]   [Full Text] [Related]  

  • 43. Alpha-particles for targeted therapy.
    Sgouros G
    Adv Drug Deliv Rev; 2008 Sep; 60(12):1402-6. PubMed ID: 18541332
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Two approaches for enhancing radioimmunotherapy: alpha emitters and hyperthermia.
    Zalutsky MR; Schuster JM; Garg PK; Archer GE; Dewhirst MW; Bigner DD
    Recent Results Cancer Res; 1996; 141():101-22. PubMed ID: 8722422
    [No Abstract]   [Full Text] [Related]  

  • 45. Targeted alpha-particle therapy of microscopic disease: Providing a further rationale for clinical investigation.
    Zalutsky MR
    J Nucl Med; 2006 Aug; 47(8):1238-40. PubMed ID: 16882999
    [No Abstract]   [Full Text] [Related]  

  • 46. Stochastic simulation of radium-223 dichloride therapy at the sub-cellular level.
    Gholami Y; Zhu X; Fulton R; Meikle S; El-Fakhri G; Kuncic Z
    Phys Med Biol; 2015 Aug; 60(15):6087-96. PubMed ID: 26216391
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alpha- versus beta-particle radiopeptide therapy in a human prostate cancer model (213Bi-DOTA-PESIN and 213Bi-AMBA versus 177Lu-DOTA-PESIN).
    Wild D; Frischknecht M; Zhang H; Morgenstern A; Bruchertseifer F; Boisclair J; Provencher-Bolliger A; Reubi JC; Maecke HR
    Cancer Res; 2011 Feb; 71(3):1009-18. PubMed ID: 21245097
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Receptor-mediated tumor targeting with radiopeptides. Part 1. General principles and methods.
    Eberle AN; Mild G
    J Recept Signal Transduct Res; 2009; 29(1):1-37. PubMed ID: 19519167
    [TBL] [Abstract][Full Text] [Related]  

  • 49. (2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted α-Particle Radiopharmaceutical Therapy.
    Kiess AP; Minn I; Vaidyanathan G; Hobbs RF; Josefsson A; Shen C; Brummet M; Chen Y; Choi J; Koumarianou E; Baidoo K; Brechbiel MW; Mease RC; Sgouros G; Zalutsky MR; Pomper MG
    J Nucl Med; 2016 Oct; 57(10):1569-1575. PubMed ID: 27230930
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The advantage of antibody cocktails for targeted alpha therapy depends on specific activity.
    Pasternack JB; Domogauer JD; Khullar A; Akudugu JM; Howell RW
    J Nucl Med; 2014 Dec; 55(12):2012-9. PubMed ID: 25349219
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patient-specific alpha-particle dosimetry.
    Palm S; Elgqvist J; Jacobsson L
    Curr Radiopharm; 2011 Oct; 4(4):329-35. PubMed ID: 22202155
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The potential radio-immunotherapeutic α-emitter
    Collins SM; Keightley JD; Ivanov P; Arinc A; Jerome SM; Fenwick AJ; Pearce AK
    Appl Radiat Isot; 2019 Mar; 145():240-250. PubMed ID: 30583971
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Alpha-Radioimmunotherapy: principle and relevance in anti-tumor immunity].
    Ménager J; Gorin JB; Fichou N; Gouard S; Morgenstern A; Bruchertseifer F; Davodeau F; Kraeber-Bodéré F; Chérel M; Gaschet J; Guilloux Y
    Med Sci (Paris); 2016 Apr; 32(4):362-9. PubMed ID: 27137693
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Alpha-radioimmunotherapy: a review of recent developments].
    Supiot S; Thillays F; Rio E; Mahé MA; Barbet FJ; Kraeber-Bodéré F; Chérel M
    Cancer Radiother; 2007 Sep; 11(5):252-9. PubMed ID: 17604673
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bone-seeking radiopharmaceuticals for treatment of osseous metastases, Part 1: α therapy with 223Ra-dichloride.
    Pandit-Taskar N; Larson SM; Carrasquillo JA
    J Nucl Med; 2014 Feb; 55(2):268-74. PubMed ID: 24343987
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ac-225 and her daughters: the many faces of Shiva.
    McDevitt MR; Scheinberg DA
    Cell Death Differ; 2002 Jun; 9(6):593-4. PubMed ID: 12032666
    [No Abstract]   [Full Text] [Related]  

  • 57. Relative biological effectiveness of high linear energy transfer α-particles for the induction of DNA-double-strand breaks, chromosome aberrations and reproductive cell death in SW-1573 lung tumour cells.
    Franken NA; Hovingh S; Ten Cate R; Krawczyk P; Stap J; Hoebe R; Aten J; Barendsen GW
    Oncol Rep; 2012 Mar; 27(3):769-74. PubMed ID: 22200791
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Palliation of Extensive Metastatic Bone Disease With 223Ra-Dichloride α-Particle Therapy in a Patient With Malignant Hereditary Paraganglioma-Pheochromocytoma Syndrome With SDHB Mutation.
    Makis W; McCann K; McEwan AJ; Sawyer MB
    Clin Nucl Med; 2016 Feb; 41(2):144-7. PubMed ID: 26359562
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Calculations related to the possible use of photons, neutrons, negatively charged pions, protons, and alpha particles in radiotherapy.
    Alsmiller RG; Santoro RT; Armstrong TW; Barish J; Chandler KC; Chapman GT
    Radiat Res; 1974 Dec; 60(3):369-87. PubMed ID: 10881718
    [No Abstract]   [Full Text] [Related]  

  • 60. [Principles, modalities and indications of the administration of Radium in cancers, focus on metastatic prostate cancer: State of arts].
    Bertolaso P; Leroy L; Gross-Goupil M; Aupee O; Ravaud A; Roubaud G; Cazeau AL; Le Moulec S
    Bull Cancer; 2017 Sep; 104(9):762-770. PubMed ID: 28797482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.